Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
131.60    0.00 (0.00%)
Bid:
131.30
Ask:
131.50
Spread: 0.20 (0.152%)
Market Cap: £332.80m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Directorate Change

28 Apr 2010 09:44

RNS Number : 9339K
Marshalls PLC
28 April 2010
 



 

28 April 2010

 

APPOINTMENT OF NON-EXECUTIVE DIRECTORS

 

Marshalls plc announces the appointment of two new non-executive directors, Alan Coppin and Mark Edwards, to take effect immediately after the next Annual General Meeting of Marshalls plc on 12 May 2010. This announcement includes the information required by Listing Rules 9.6.11 to 9.6.13.

 

Alan Coppin is a non-executive director of Berkeley Group Holdings plc and Capital and Regional Plc, and was previously Chairman of Redstone Plc and a director of Carillion plc. Between 1988 and 1998 he was Chief Executive of Wembley plc, and subsequently Chief Executive of the Global Operating Division of Compass plc. He is also a non-executive director of the Royal Air Force and a patron of the Windsor Leadership Trust. He has wide experience in both governance and management, with particular focus on marketing and the leisure industry.

 

Mark Edwards is a chartered accountant with extensive experience in the manufacturing sector, most recently as Chief Executive of Baxi Group. He was formerly Finance Director of the Security and Building Products Division of Williams plc, and has held a number of other senior finance positions. He was a director of Heating Finance plc between 2004 and 2008. He is also a former Vice President of the Construction Products Association.

 

Richard Scholes, who has served on the Board since 2003, will be stepping down from the Board immediately after the 2010 Annual General Meeting. Alan Coppin is expected to succeed Richard Scholes as Senior Independent Director and will also chair the Remuneration Committee. Mark Edwards will succeed Richard Scholes as Chairman of the Audit Committee.

 

Mike Davies, Chairman, commented: "The Board would like to record its thanks to Richard Scholes for his valuable contribution during his term of office. Both I and Andrew Allner, Chairman-Designate, are delighted we have been able to attract to the Board two new non-executive directors of such high calibre, and the Board is looking forward to benefiting from their extensive skills and experience".

 

 

Enquiries:

Graham Holden - Chief Executive

Andrew Allner - Chairman-Designate

Telephone number: 01484 438900

 

 

Jon Coles - Brunswick

Telephone number: 020 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUWOWRRWASURR
Date   Source Headline
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding
11th Aug 20251:57 pmRNSDirector/PDMR Shareholding
11th Aug 20257:00 amRNSHalf year results
7th Aug 20257:00 amRNSDirectorate Change
28th Jul 202512:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.